Borchmann, P., Viardot, A., Wermke, M., Subklewe, M., Siddiqi, T., Jaeger, U., Hasskarl, J. and Abramson, J. S. (2018). Results of the phase I transcend NHL 001 trial of JCAR017 support the phase II transcend world study of this Chimeric Antigen Receptor (CAR) T-Cell therapy in patients (Pts) with aggressive B-Cell Non-Hodgkin Lymphoma (B-NHL). Oncol. Res. Treat., 41. S. 37 - 38. BASEL: KARGER. ISSN 2296-5262

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Borchmann, P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Viardot, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wermke, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Subklewe, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Siddiqi, T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jaeger, U.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hasskarl, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Abramson, J. S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-201416
Journal or Publication Title: Oncol. Res. Treat.
Volume: 41
Page Range: S. 37 - 38
Date: 2018
Publisher: KARGER
Place of Publication: BASEL
ISSN: 2296-5262
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
OncologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/20141

Downloads

Downloads per month over past year

Export

Actions (login required)

View Item View Item